What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
His primary areas of study are Internal medicine, Pediatrics, Parkinsonism, Central nervous system disease and Pathology.
His Internal medicine study incorporates themes from Gastroenterology and Endocrinology.
His research integrates issues of Surgery, Retrospective cohort study, Dyskinesia and Incidence in his study of Pediatrics.
The Dyskinesia study combines topics in areas such as Levodopa, Meta-analysis and Neurological disorder.
Effective treatment is closely connected to Psychiatry in his research, which is encompassed under the umbrella topic of Parkinsonism.
J. Eric Ahlskog has included themes like Depression and Cardiology in his Central nervous system disease study.
His most cited work include:
- Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature (1054 citations)
- Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging (490 citations)
- Pathological gambling caused by drugs used to treat Parkinson disease. (458 citations)
What are the main themes of his work throughout his whole career to date?
J. Eric Ahlskog mainly focuses on Internal medicine, Parkinson's disease, Parkinsonism, Pediatrics and Surgery.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Endocrinology.
J. Eric Ahlskog is interested in Levodopa, which is a field of Parkinson's disease.
His work deals with themes such as Movement disorders, Retrospective cohort study and Atrophy, which intersect with Parkinsonism.
His Pediatrics study integrates concerns from other disciplines, such as Medical record, Psychiatry, Cohort study and Age of onset.
In his study, Botulinum toxin is inextricably linked to Dystonia, which falls within the broad field of Surgery.
He most often published in these fields:
- Internal medicine (23.77%)
- Parkinson's disease (22.42%)
- Parkinsonism (21.52%)
What were the highlights of his more recent work (between 2014-2021)?
- Parkinsonism (21.52%)
- Pediatrics (20.63%)
- Internal medicine (23.77%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Parkinsonism, Pediatrics, Internal medicine, Atrophy and Rochester Epidemiology Project.
His Parkinsonism research is within the category of Disease.
His studies deal with areas such as Levodopa, Polysomnogram and Medical record as well as Pediatrics.
His research in Levodopa intersects with topics in Botulinum toxin, Trihexyphenidyl, Symptomatic treatment, Dystonia and Physical therapy.
His Internal medicine research includes elements of Gastroenterology, EMG abnormality and Dysphagia.
His work on Progressive supranuclear palsy as part of general Atrophy study is frequently connected to Autonomic reflex, Autonomic testing and Orthostatic intolerance, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Between 2014 and 2021, his most popular works were:
- Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures. (105 citations)
- Time Trends in the Incidence of Parkinson Disease (104 citations)
- Clinical features and autonomic testing predict survival in multiple system atrophy (70 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
Parkinsonism, Pediatrics, Rochester Epidemiology Project, Pathology and Internal medicine are his primary areas of study.
Parkinsonism is the subject of his research, which falls under Disease.
His Pediatrics research incorporates elements of Cognitive impairment, Neuropsychology, Tau pathology, Cause of death and Dementia.
His work carried out in the field of Pathology brings together such families of science as Executive dysfunction and Midbrain.
His Internal medicine research includes themes of Gastroenterology, Minor allele frequency and Cerebellar ataxia.
His research in Cohort study intersects with topics in Relative risk, Levodopa, Dyskinesia, Levodopa-induced dyskinesia and Severity of illness.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
